Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes

BACKGROUND: For rheumatoid arthritis (RA), the treat-to-target concept suggests attaining remission or at least low disease activity (LDA) after 12 weeks. OBJECTIVES: This German, prospective, multicenter, non-interventional study aimed to determine the proportion of patients with RA who achieved th...

Descripción completa

Detalles Bibliográficos
Autores principales: Feist, Eugen, Baraliakos, Xenofon, Behrens, Frank, Thaçi, Diamant, Klopsch, Thilo, Plenske, Anja, Blindzellner, Lisa K., Klaus, Pascal, Meng, Thomas, Löschmann, Peter-Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964852/
https://www.ncbi.nlm.nih.gov/pubmed/35113363
http://dx.doi.org/10.1007/s40744-021-00418-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964852/
https://www.ncbi.nlm.nih.gov/pubmed/35113363
http://dx.doi.org/10.1007/s40744-021-00418-5

Ejemplares similares